Novartis Prepares for UK Luxturna Rollout After Rapid NICE OK

Eye
NICE has OKd Luxturna for a rare eye disorder
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Drug Pricing

More from Scrip